Targeting gene rearrangements shows promise in early studyApril 19, 2016Lung CancerCNS/Brain CancerGastroenterologySarcoma & GISTGastrointestinal Cancer
Adding chemo to radiation boosts survival from low-grade gliomasApril 6, 2016CNS/Brain CancerNeuro-oncology
Temsirolimus results in good but short-duration responses in primary CNS lymphomaMarch 14, 2016Neuro-oncologyCNS/Brain CancerLymphoma & Plasma Cell Disorders
Children’s cancer survival steadily increasingMarch 1, 2016PediatricsCNS/Brain CancerLymphoma & Plasma Cell DisordersPatient & Survivor Care
Danish study finds increased glioma risk in a rosacea populationFebruary 9, 2016Neuro-oncologyCNS/Brain Cancer
Proton radiotherapy effective for childhood medulloblastomaJanuary 29, 2016CNS/Brain CancerNeuro-oncologyPediatrics
Tumor-treating fields may improve outcomes in glioblastomaDecember 18, 2015CNS/Brain CancerNeuro-oncology
IDH1 mutant inhibitor targets gliomas, chondrosarcomasNovember 16, 2015Sarcoma & GISTCNS/Brain Cancer
Tumor location, radiotherapy predict neuroendocrine dysfunction after pediatric gliomaAugust 6, 2015CNS/Brain CancerPatient & Survivor CareRare DiseasesPediatrics
FDA investigating risk of gadolinium contrast agent brain depositsAugust 5, 2015Neuro-oncologyCNS/Brain Cancer
Anticoagulant therapy not contraindicated in brain metastasesAugust 3, 2015CNS/Brain CancerPatient & Survivor Care
ASCO: Trial highlights cognitive toll of adjuvant whole-brain radiationJune 2, 2015CNS/Brain CancerNeuro-oncology
Alzheimer’s drug improves cognitive function after RT for brain tumorsApril 20, 2015Neuro-oncologyCNS/Brain CancerPatient & Survivor Care
FDA approves first drug for high-risk neuroblastomaMarch 10, 2015CNS/Brain CancerRare DiseasesNeuro-oncology
